To the best of our knowledge, locaserin has not been tested in PTD-induced weight gain, but its receptor profile suggests it may be beneficial as an adjunct in clozapine-, olanzapine-, or mirtazapine-treated patients
: : - (BMI)
According to the Summary of Product Characteristics (SmPCs), GLP-1 medications commonly cause nausea (reported in approximately 20-40% of patients with semaglutide and 12-21% with dulaglutide), vomiting, and diarrhoea, particularly during initial treatment and dose escalation
Many of our patients use multiple peptides to address different goals simultaneously
For example, probiotics can support digestive health, and magnesium supplements can help prevent semaglutide constipation
For patients worried about affordability, our guide on how to get insurance to cover revision bariatric surgery walks through the exact documentation most commercial and Medicare plans require